Fahma Amal, Subair Suhail, Ramakrishnan Krishnapriya, Ravi Vishal, Raju Rajesh, Rehman Niyas
Centre for Integrative Omics Data Science (CIODS), Yenepoya (Deemed to Be University), Mangalore, 575018, India.
Curr Microbiol. 2025 Jul 7;82(8):366. doi: 10.1007/s00284-025-04336-5.
Gastric cancer (GC) is the fifth most prevalent cancer worldwide, with Helicobacter pylori (H. pylori) infection as the leading cause. MicroRNAs (miRNAs), critical post-transcriptional regulators of gene expression, play pivotal roles in both H. pylori infection and GC pathogenesis. However, not all the dysregulated miRNAs exert a downstream effect on mRNAs, steering the pathologies. Utilising GEO datasets and literature curation, we compiled a comprehensive list of human differentially expressed (hDE) miRNAs in H. pylori-infected cell lines (HP-hDEmiRs) and GC tissues (GC-hDEmiRs). The identified targets of hDEmiRs from publicly available databases were compared with hDEmRNAs retrieved from GEO in each pathology to build a miRNA-mRNA network exhibiting inverse expression patterns, and the resultant miRNAs were considered as 'Functional hDEmiRs'. Subsequently, 24 upregulated and 10 downregulated functional HP-hDEmiRs with 57 and 18 targets and 38 upregulated and 7 downregulated functional GC-hDEmiRs with 230 and 20 targets were identified, respectively. The miRNA-mRNA network of functional GC-hDEmiRs was validated using GC-hDEmRNAs from TCGA and a shared subset of functional hDEmiRs in H. pylori infection and GC was identified. This includes the upregulated hsa-miR-98-5p, hsa-miR-21-5p, hsa-let-7c-5p, hsa-let-7f-5p, hsa-let-7i-5p, hsa-miR-15a-5p, hsa-miR-181b-5p, hsa-miR-25-3p and the downregulated hsa-miR-204-5p, that could have a combinatorial effect in H. pylori infection to GC progression. Moreover, along with the TCGA-validated hydroxyacyl-CoA dehydrogenase (HADH), the epithelial splicing regulatory protein-2 (ESRP2) and dihydrolipoamide branched chain transacylase E2 (DBT) were downregulated in both conditions, possibly attributed to the effect of functional hDEmiRs targeting them. Our findings offer potential candidates for miRNA-directed therapeutics in these pathologies.
胃癌(GC)是全球第五大常见癌症,幽门螺杆菌(H. pylori)感染是其主要病因。微小RNA(miRNA)是基因表达的关键转录后调节因子,在幽门螺杆菌感染和胃癌发病机制中均起关键作用。然而,并非所有失调的miRNA都会对mRNA产生下游影响,从而影响疾病进程。利用基因表达综合数据库(GEO)数据集和文献整理,我们编制了一份幽门螺杆菌感染细胞系(HP-hDEmiRs)和胃癌组织(GC-hDEmiRs)中人类差异表达(hDE)miRNA的综合列表。将从公开数据库中鉴定的hDEmiRs靶标与从GEO中检索到的每种病理状态下的hDEmRNA进行比较,以构建呈现反向表达模式的miRNA-mRNA网络,并将所得的miRNA视为“功能性hDEmiRs”。随后,分别鉴定出24个上调和10个下调的功能性HP-hDEmiRs,它们分别有57个和18个靶标,以及38个上调和7个下调的功能性GC-hDEmiRs,它们分别有230个和20个靶标。使用来自癌症基因组图谱(TCGA)的GC-hDEmRNA对功能性GC-hDEmiRs的miRNA-mRNA网络进行了验证,并鉴定出幽门螺杆菌感染和胃癌中功能性hDEmiRs的共享子集。这包括上调的hsa-miR-98-5p、hsa-miR-21-5p、hsa-let-7c-5p、hsa-let-7f-5p、hsa-let-7i-5p、hsa-miR-15a-5p、hsa-miR-181b-5p、hsa-miR-25-3p和下调的hsa-miR-204-5p,它们在幽门螺杆菌感染到胃癌进展过程中可能具有协同作用。此外,除了经TCGA验证的羟酰基辅酶A脱氢酶(HADH)外,上皮剪接调节蛋白2(ESRP2)和二氢硫辛酰胺支链转酰基酶E2(DBT)在这两种情况下均下调,这可能归因于靶向它们的功能性hDEmiRs的作用。我们的研究结果为这些疾病中基于miRNA的治疗提供了潜在的候选靶点。